Trial NCT03768726

View at ClinicalTrials.gov 
Org. Study IDs: A1281201

Last trial update was posted on 2021-06-16

MeSH Interventions

Ziprasidone

MeSH Conditions

Bipolar Disorder

Other Conditions


Stopping Reasons

Pfizer has decided to perform the pre-specified final analysis at the current enrollment using a re-estimation of the sample size.

Limitations And Caveats

Prioritization of outcome measures per study team's discretion.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID